My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

BioCryst Pharmaceuticals, Inc. - Common Stock (NQ:BCRX)

6.845 +0.295 (+4.50%)

Streaming Delayed Price Updated: 3:21 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioCryst Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Is BioCryst a Good Stock to Buy Now? ↗

May 21, 2021

This commercial-stage drugmaker trades for less than many of its clinical-stage peers.

Via The Motley Fool

The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics ↗

May 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Alexion Pharmaceuticals, Inc...

Via Benzinga

Why BioCryst Pharmaceuticals Stock Is Jumping Today ↗

May 17, 2021

Investors appear to be increasingly optimistic about the outlook for its drug Orladeyo.

Via The Motley Fool

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

May 14, 2021

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...

Via Benzinga

Why BioCryst Pharmaceuticals' Stock Is Trading Higher Today ↗

May 06, 2021

BioCryst Pharmaceuticals (NASDAQ:BCRX) shares are tra...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO ↗

May 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...

Via Benzinga

Is BioCryst Pharmaceuticals A Good Biotech Stock To Own? ↗

May 12, 2021

Growing investor interest in the bio-pharmaceuticals industry, combined with various technology innovations leading to breakthrough drug trials, have allowed BCRX to generate $19.10 million in revenues...

Via Talk Markets

BioCryst Pharmaceuticals (BCRX) Q1 2021 Earnings Call Transcript ↗

May 06, 2021

BCRX earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

72 Biggest Movers From Yesterday ↗

May 07, 2021

Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 85.8% to settle at $10.22 on above-average volume. Liquidity Services, Inc. (NASDAQ: LQDT) jumped 37.7% to settle at $25...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 06, 2021

Gainers Lexaria Bioscience (NASDAQ:LEXX) shares rose 53.87% to $7.74 during Thursday's regular session. As of 12:30 EST, Lexaria Bioscience's stock is trading at a...

Via Benzinga

BioCryst Shares Trading Higher As Q1 Sales Beat Was Supported By Orladeyo Revenues ↗

May 06, 2021

BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) reported a first-quarter loss of $0.36, wider than the consensus loss of $0.27 and deeper than the EPS loss of $0.24...

Via Benzinga

Topics Earnings

Why BioCryst Pharmaceuticals Stock Is Soaring Today ↗

May 06, 2021

The drugmaker reported better-than-expected Q1 results.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 06, 2021

Gainers Stealth BioTherapeutics (NASDAQ:MITO) stock moved upwards by 58.33% to $1.9 during Thursday's pre-market session. The market value of their outstanding shares...

Via Benzinga

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

April 16, 2021

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...

Via Benzinga

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 16, 2021

Gainers BioCryst Pharmaceuticals (NASDAQ:BCRX) shares rose 11.13% to $11.32 during Friday's regular session. As of 08:06 EST, this security is trading at a volume of 8...

Via Benzinga

Mid-Day Market Update: Dow Surges 250 Points; KLX Energy Services Shares Slide ↗

April 15, 2021

Midway through trading Thursday, the Dow traded up 0.75% to 33,983.24 while the NASDAQ rose 1.02% to 13,999.22. The S&P also rose, gaining 0.85% to 4,159.64. The U.S. has the...

Via Benzinga

Topics Stocks

Why BioCryst Pharmaceuticals Stock Is Popping Today ↗

April 14, 2021

Investors cheered good news out of Japan for the company's lead product.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.